Evidence map›Paper›PMID 31666104›Full record

ArticleJournal of experimental & clinical cancer research : CR2019

Correction to: The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway.

Sahyun Pak, Sejun Park, Yunlim Kim, Jung-Hyuck Park, Chan-Hee Park, Kyoung-June Lee, Choung-Soo Kim, Hanjong Ahn

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Oncology letters · 2020
    Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Sahyun PakDepartment of Urology, Center for Urologic Cancer, National Cancer Center, Goyang, South Korea.
Sejun ParkDepartment of Urology, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, South Korea.
Yunlim KimDepartment of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Jung-Hyuck ParkDrug Discovery Center, JW Pharmaceutical Corporation, Seoul, South Korea.
Chan-Hee ParkDrug Discovery Center, JW Pharmaceutical Corporation, Seoul, South Korea.
Kyoung-June LeeJW Creagene Corporation, Seongnam, South Korea.
Choung-Soo KimDepartment of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Hanjong AhnDepartment of Urology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea. hjahn@amc.seoul.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication of this article [1], there are mistakes in Fig. 4d. The corrected Fig. 4 should be.

Identifiers

PMID31666104
PMCPMC6822452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.